The development of evidence-based European guidelines on the management of @entity308 in palliative XXXX care.

@entity1 @entity308 @entity5 @entity1442 @entity158
@entity308 is common in @entity5 @entity1 , particularly those with @entity1442 . It is associated with adverse outcomes such as @entity158 , disability and poorer prognosis. Our aim was to produce a European evidence-based clinical guideline on the management of @entity308 in @entity1 receiving palliative care to inform practice, establish policy, promote European consensus and ultimately improve @entity1 outcomes. Recommendations were devised using the best available evidence. Where evidence was absent or equivocal, Delphi consensus methods were implemented to elicit and refine expert opinion. Evidence was graded according to the process proposed by GRADE. The resulting guideline has three main sections: (1) prevention; (2) detection, diagnosis and assessment; and (3) treatment. The prevention section outlines strategies such as optimal palliative care and support, effective communication and information-giving. The detection section provides recommendations on symptoms, screening, diagnosis and severity assessment. The treatment section gives guidance on treatment decisions including choice of psychological therapy and antidepressant medication. This is the first comprehensive, evidence-based guideline on managing @entity308 in palliative care. It has the potential to improve @entity1 outcomes by enabling clinicians to access and implement evidence-based knowledge quickly and easily.
